Stage IA Breast Cancer Completed Phase 2 Trials for Trimetrexate (DB01157)

IndicationStatusPhase
DBCOND0029217 (Stage IA Breast Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs